Alnylam Pharmaceuticals (ALNY) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open. – The consensus EPS Estimate is $2.25 (-22.4% Y/Y) and the consensus Revenue Estimate is $1.43B (+15.3% Y/Y). – Over the last 2 years, ALNY
Alnylam Pharmaceuticals Q3 2026 Earnings Preview
Alnylam Pharmaceuticals (ALNY) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open. - The consensus EPS Estimate is $2.25 (-22.4% Y/Y) and the consensus Revenue Estimate is $1.43B (+15.3% Y/Y). - Over the last 2 years, ALNY